EMEA-000717-PIP02-13-M02

  • Email
  • Help

Overview

Product details for -
Invented name-
Active substance

Vigabatrin

Decision numberP/0083/2017
PIP numberEMEA-000717-PIP02-13-M02
Pharmaceutical form(s)Soluble tablet
Condition(s)/indication(s)

Treatment of epilepsy

Route(s) of administrationOral use
PIP applicant

Orphelia Pharma SA
France
E-mail: contact@orphelia-pharma.eu
Tel. +33 1427 70818

Decision typePM: decision on the application for modification of an agreed PIP
Compliance check procedure numberEMEA-C-000717-PIP02-13-M02
Compliance check opinion date21/07/2017
Compliance check outcomePositive

Decision